Sanyo dual-cooling freezer provides sample security
The upright 728l model is ideal for valuable research or clinical samples
With two independent refrigeration systems the dual-cooling freezers maintain a reliable and uniform -86°C ultralow temperature environment. Should one cooling system suffer an unexpected failure, the other circuit will keep irreplaceable samples safely around -70°C until service can be arranged. This freezer design not only protects precious samples but also prevents the inconvenience and expense of out-of-hours call-outs in the event of a failure of one of the refrigeration systems.
The MDF-U700VX has an extra-large capacity of 728 litres without taking up extra space, thanks to its VIP Plus high efficiency vacuum insulation. In addition to reducing energy use, VIP Plus provides typically 24% more storage capacity compared with a conventionally insulated freezer with the same footprint.
This latest dual-cooling unit offers Sanyo’s industry-first intelligent ECO Mode, optimising compressor operation to match the freezer’s running conditions and minimise energy use. Efficient long-term operation of the freezer is facilitated by the filter-less condenser design, which eliminates the need for routine filter cleaning.
The central door-mounted LCD display panel provides intuitive programming of set points and clear confirmation of freezer status. An on-board data logging function allows the operator to easily check recent freezer performance. Other user-friendly design features include comprehensive alarms, a vacuum release port for smooth door opening, and quiet operation.
The MDF-U700VX is certified as a Class IIa Medical Device (93/42/EEC and 2007/47/EC).
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Research & Development
Scientists develop new technique to fight antimicrobial resistance
The team of researchers from the University of Leicester have developed a new technique to sequence phage genomes from individual plaques and hopes to use it to build fully characterised libraries of bacteriophages, expanding the number of candidates available to tackle drug-resistant infections
Research & Development
Lancet Oncology Commission launches to examine future of academic cancer clinical trials amid funding and regulatory pressures
A global coalition of clinical investigators and patient representatives has launched the Lancet Oncology Commission to address the value and challenges of independent academic cancer clinical trials, amid growing concerns over regulatory complexity, limited public funding and the need for new international collaboration models